-
![]()
"The MARC SE-Africa project comes at a time when evidence is much needed to address the challenges posed by drug-resistant malaria."
Joaniter Nankabirwa
-
![]()
“Antimalarial drug resistance is a major threat to global malaria control efforts, and a multifaceted approach is required to tackle it. That is why I am passionate about the MARC SE-Africa project."
Donnie Mategula
-
![]()
"The MARC SE-Africa consortium is all about bringing people together to help tackle the threat of drug resistant malaria to make sure patients get effective treatment."
Karen Barnes
-
![]()
“With a focus on Africa and globally, MARC SE-Africa is a crucial initiative that aims to address the emerging threat of antimalarial drug resistance."
Aline Uwimana
-
![]()
"As public health professionals, we know that collaboration is a proven way to fast-track better outcomes for patients."
Philippe Guerin
Team
The Mitigating Antimalarial Resistance Consortium for South-East Africa (MARC SE-Africa) is comprised of ten organisations from nine countries on three different continents that all work together to achieve a common goal: To better define the extent of antimalarial resistance regionally and even more importantly expedite the sharing of such evidence with National Malaria Programmes and their implementation partners.
The breadth of research expertise in the broadly inter-disciplinary consortium includes malaria epidemiology, social sciences, clinical pharmacology, infectious diseases medicine, molecular biology, biomedical statistics and mathematical modelling, as well as public health and health policy.
MARC SE-Africa is coordinated by Prof Karen I Barnes from the University of Cape Town (UCT) and supported by LINQ management GmbH (LINQ).
-
University Of Cape Town (UCT) / Collaborating Centre for Optimising Antimalarial Therapy (CCOAT)
South Africa
-
Prof Karen I Barnes
-
Marilyn Solomons
-
Dr Stephanie Van Wyk
-
Dr Elizabeth Allen
Strategic Partnerships Lead (TGHN)
-
Dr Jaishree Raman
-
Dr Joanitah Atuhaire
Postdoctoral Research Fellow
-
Dr Jonathan Gwasupika
Clinical Research Fellow
-
WorldWide Antimalarial Resistance Network of the University of Oxford (WWARN/UOXF)
United Kingdom
-
Prof Philippe Guerin
Principal Investigator
-
Kalynn Kennon
Head of Data Engineering
-
Caitlin Richmond
Programme Manager
-
Samantha McGregor
Communications Officer
-
Dr Charvy Narain
Communications Officer
-
-
Prof Abdoulaye Djimdé
University of Science, Techniques and Technologies of Bamako, Mali
-
Dr Leah Moriarty
President's Malaria Initiative
Partnership for Antimalarial Resistance Monitoring in Africa (PARMA)
-
Dr Noella Umulisa
Jhpiego Rwanda/ RBM Case Management working group
-
Dr Lumbani Munthali
NMP SADC Malawi Ministry of Health